Literature DB >> 3318413

The familial occurrence of focal segmental glomerular sclerosis.

F A McCurdy1, P J Butera, R Wilson.   

Abstract

We have observed the occurrence of focal segmental glomerulosclerosis in all three siblings of a single Hispanic family. Each of the children had the onset of significant proteinuria on or before the age of 10. The two oldest children have had progression of their disease to end-stage with subsequent successful transplantation. The youngest sibling continues to have normal renal function. All three patients had renal biopsies prior to the onset of renal insufficiency and each of the biopsies showed the presence of focal segmental glomerulosclerosis with mild diffuse mesangial hypercellularity. Finally, HLA-typing revealed the presence of DRw8 in all three siblings and the father. This report further suggests that genetic factors may be quite important in the development of the lesion of focal segmental glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318413     DOI: 10.1016/s0272-6386(87)80195-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number.

Authors:  C He; C Esposito; C Phillips; R K Zalups; D A Henderson; G E Striker; L J Striker
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

2.  Nephrotic syndrome in a mother and her infant: relationship with cytomegalovirus infection.

Authors:  M Giani; A Edefonti; B Damiani; G Marra; D Colombo; G Banfi; E Rivolta; E H Strøm; M Mihatsch
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

3.  Spondyloepiphyseal dysplasia tarda and nephrotic syndrome in three siblings.

Authors:  G Lama; N Marrone; M Majorana; F Cirillo; M E Salsano; M M Rinaldi
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.